Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 3:57 AM
Study NCT ID:
NCT07311993
Status:
RECRUITING
Last Update Posted:
2026-01-09
First Post:
2025-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Sponsor:
Cellectar Biosciences, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DCL-25-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None